ENDV
Endonovo Therapeutics Inc
Price:
0
USD
Volume:
1,853,890
United States | Biotechnology
ENDV Gross Margin
As of 2025-05-30, the Gross Margin of Endonovo Therapeutics Inc (ENDV) is 92.6%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
ENDV Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2022-12-31 | 92.6% |
| 2021-12-31 | 79.5% |
| 2020-12-31 | 60.6% |
| 2019-12-31 | 69.9% |
| 2018-12-31 | 84.5% |
| 2017-12-31 | - |
| 2016-12-31 | - |
| 2015-12-31 | 49.4% |
| 2014-12-31 | 36% |
| 2013-12-31 | 38.9% |
ENDV Gross Margin - Peers Comparison